Le Lézard
Classified in: Sports and recreation
Subject: LICENSING AGREEMENTS

TJP Labs Inc. Is Granted Drug Establishment Licensing (DEL) by Health Canada


PICKERING, Ontario, July 19, 2022 (GLOBE NEWSWIRE) -- TJP Labs Inc. ("TJP Labs") is North America's leading full-service contract manufacturer of next-generation products, focusing on Modern Oral Nicotine pouches and oral delivery solutions for energy and nutraceutical products. After completing a thorough

regulatory assessment and meeting all GMP requirements, Health Canada has granted TJP Labs Inc. a Drug Establishment License (DEL).

Any company that intends to import, fabricate, package, label, or distribute pharmaceutical drugs must obtain a Drug Establishment License per Health Canada regulatory requirements. It is a comprehensive and stringent process to achieve DEL approval as a company must demonstrate it meets strict quality control standards and procedures. 

The Drug Establishment License aligns with TJP Labs' future goal to offer drug manufacturing services. Further, it augments TJP's globally recognized expertise in full-service contract manufacturing in the next-generation nicotine and nutraceutical space.

Speaking on the achievement, David Richmond-Peck, CEO of TJP Labs, said:

"We are incredibly excited at the future possibilities Drug Establishment Licensing offers our global customers. We founded TJP Labs to promote global harm reduction and develop products appropriate for the protection of public health. Passing the rigorous inspection process conducted by Health Canada is evidence that the unparalleled quality of our best-in-class manufacturing facility aligns with our corporation's long-term objectives.

This license, including our Natural Health Products Site License, ISO 9001:2015, HACCP and cGMP certifications, speaks to the rigorous quality standards at TJP Labs. It propels our vision to become a global leader in modern oral nicotine, energy, and nutraceutical pouch manufacturing. Further, it reinforces our ability to service high-volume brands in international markets."

About TJP Labs Inc. 
TJP Labs is a leading North American full-service, global contract manufacturer of premium quality next-generation products, specializing in modern oral nicotine, energy, and nutraceutical pouches. Our products are manufactured and packaged in our DEL, Site-Licensed, cGMP/HACCP compliant, ISO 9001:2015 certified state-of-the-art facilities.

Contacts

David Richmond-Peck - [email protected]

Website: www.tjplabs.com



These press releases may also interest you

17 mai 2024
The champion players of the Las Vegas Aces are getting a cash boost, direct from Vegas. Today the Las Vegas Convention and Visitors Authority (LVCVA) announced that it will sponsor each player on the team, resulting in a first-of-its-kind, two-year...

17 mai 2024
Celebrities around the globe have long been captivated by the allure of the Maldives, and according to Björn Ingbrant, CEO of Maldives-Paradise.com, the reasons behind their holiday escapes to this tropical haven are multifaceted. In an...

17 mai 2024
Olight, the world's leading brand in mobile lighting solutions, today officially unveiled its latest product line ? Osight, an optic with a charging cover, at the company's product release event during this year's NRA Show....

17 mai 2024
Rally House, the nationally known sports and merchandise retailer, expands presence in Wisconsin to two storefront locations after opening Rally House Outlets at The Dells in Baraboo this Friday. Rally House Outlets at The Dells can be found off...

17 mai 2024
Today at the Indianapolis Motor Speedway (IMS), Cummins Inc. and Valvoline Global Operations celebrate Andrew McDougall ? who was honored with the 2024 Louis Schwitzer Award for his Xtrac Electric Servo Actuator, which has been adopted by the NTT...

17 mai 2024
Greenlite Ventures, Inc. has announced the signing of an Acquisition Agreement with No Limit Technology Holdings, Inc. (NLTH), an emerging powerhouse in the Sports Betting arena. The Agreement is scheduled to be finalized following a 30?45-day due...



News published on and distributed by: